Company Filing History:
10 out of 18 
2 out of 3 
2 out of 410 
Years Active: 2017-2025
Title: Kjell Sjöström: Innovator in Antibody Polypeptides
Introduction
Kjell Sjöström is a prominent inventor based in Lund, Sweden, known for his significant contributions to the field of biotechnology. With a total of 12 patents to his name, he has made remarkable advancements in the development of antibody polypeptides, particularly in relation to cancer treatment.
Latest Patents
Among his latest patents, one notable invention is focused on antibody polypeptides with binding specificity for prostate-specific antigen (PSA). This invention provides antibody polypeptides that include specific amino acid sequences, which are crucial for the diagnosis and treatment of prostate cancer. Another significant patent involves methods of treating IL1RAP associated cancers using antibodies that inhibit the binding of the antibody 'CAN04' to human IL1RAP. This invention has potential applications in the treatment and diagnosis of various IL-1 associated diseases, including acute myeloid leukemia and melanoma.
Career Highlights
Kjell has worked with several companies throughout his career, including Cantargia AB and Fredax AB. His work in these organizations has contributed to the advancement of therapeutic solutions in the field of oncology.
Collaborations
Kjell has collaborated with notable professionals in his field, including Karin Von Wachenfeldt and Cecilia Ann-Christin Malmborg Hager. These collaborations have further enhanced his research and development efforts.
Conclusion
Kjell Sjöström's innovative work in antibody polypeptides showcases his dedication to improving cancer treatment options. His contributions to biotechnology continue to have a lasting impact on the medical field.